Shanghai Pharmaceuticals Holding 대차 대조표 상태
재무 상태 기준 확인 5/6
Shanghai Pharmaceuticals Holding has a total shareholder equity of CN¥83.2B and total debt of CN¥48.4B, which brings its debt-to-equity ratio to 58.2%. Its total assets and total liabilities are CN¥223.7B and CN¥140.6B respectively. Shanghai Pharmaceuticals Holding's EBIT is CN¥8.6B making its interest coverage ratio -346. It has cash and short-term investments of CN¥42.4B.
주요 정보
58.2%
부채 비율
CN¥48.42b
부채
| 이자 보상 비율 | -346x |
| 현금 | CN¥42.39b |
| 주식 | CN¥83.16b |
| 총 부채 | CN¥140.58b |
| 총 자산 | CN¥223.74b |
최근 재무 상태 업데이트
Shanghai Pharmaceuticals Holding (SHSE:601607) Has A Somewhat Strained Balance Sheet
Jun 25
We Think Shanghai Pharmaceuticals Holding (SHSE:601607) Can Stay On Top Of Its Debt
Feb 29Recent updates
Not Many Are Piling Into Shanghai Pharmaceuticals Holding Co., Ltd (SHSE:601607) Just Yet
Sep 30Shanghai Pharmaceuticals Holding (SHSE:601607) Has Some Way To Go To Become A Multi-Bagger
Aug 09Shanghai Pharmaceuticals Holding's (SHSE:601607) Dividend Is Being Reduced To CN¥0.41
Jul 18Shanghai Pharmaceuticals Holding (SHSE:601607) Has A Somewhat Strained Balance Sheet
Jun 25Shanghai Pharmaceuticals Holding Co., Ltd's (SHSE:601607) Earnings Are Not Doing Enough For Some Investors
May 21Earnings Miss: Shanghai Pharmaceuticals Holding Co., Ltd Missed EPS By 30% And Analysts Are Revising Their Forecasts
Apr 01Returns At Shanghai Pharmaceuticals Holding (SHSE:601607) Appear To Be Weighed Down
Mar 16We Think Shanghai Pharmaceuticals Holding (SHSE:601607) Can Stay On Top Of Its Debt
Feb 29재무 상태 분석
단기부채: 601607's short term assets (CN¥173.8B) exceed its short term liabilities (CN¥129.5B).
장기 부채: 601607's short term assets (CN¥173.8B) exceed its long term liabilities (CN¥11.1B).
부채 대 자본 내역 및 분석
부채 수준: 601607's net debt to equity ratio (7.3%) is considered satisfactory.
부채 감소: 601607's debt to equity ratio has reduced from 64.8% to 58.2% over the past 5 years.
부채 범위: 601607's debt is not well covered by operating cash flow (11.8%).
이자 보장: 601607 earns more interest than it pays, so coverage of interest payments is not a concern.